Form 8-K - Current report:
SEC Accession No. 0000950170-24-087391
Filing Date
2024-07-29
Accepted
2024-07-29 17:30:08
Documents
16
Period of Report
2024-07-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrn-20240725.htm   iXBRL 8-K 54302
2 EX-10.1 amrn-ex10_1.htm EX-10.1 230677
3 GRAPHIC img195770556_0.jpg GRAPHIC 675
4 GRAPHIC img195770556_1.jpg GRAPHIC 5928
5 GRAPHIC img195770556_2.jpg GRAPHIC 651
6 GRAPHIC img195770556_3.jpg GRAPHIC 651
  Complete submission text file 0000950170-24-087391.txt   467517

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20240725.xsd EX-101.SCH 32938
19 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20240725_htm.xml XML 5143
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 241153602
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)